nodes	percent_of_prediction	percent_of_DWPC	metapath
Isoprenaline—PIK3R1—CXCR3-mediated signaling events—CXCL11—nasal cavity cancer	0.0241	0.0241	CbGpPWpGaD
Isoprenaline—PIK3R3—Toll-like Receptor Signaling Pathway—CXCL11—nasal cavity cancer	0.017	0.017	CbGpPWpGaD
Isoprenaline—MAPK1—CXCR3-mediated signaling events—CXCL11—nasal cavity cancer	0.0164	0.0164	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling events regulated by Ret tyrosine kinase—FRS2—nasal cavity cancer	0.0139	0.0139	CbGpPWpGaD
Isoprenaline—PIK3R2—Toll-like Receptor Signaling Pathway—CXCL11—nasal cavity cancer	0.0135	0.0135	CbGpPWpGaD
Isoprenaline—MAPK1—Frs2-mediated activation—FRS2—nasal cavity cancer	0.0135	0.0135	CbGpPWpGaD
Isoprenaline—PIK3R3—Regulation of toll-like receptor signaling pathway—CXCL11—nasal cavity cancer	0.0132	0.0132	CbGpPWpGaD
Isoprenaline—MAPK1—Prolonged ERK activation events—FRS2—nasal cavity cancer	0.0127	0.0127	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by FGFR mutants—FRS2—nasal cavity cancer	0.0124	0.0124	CbGpPWpGaD
Isoprenaline—PIK3R3—Constitutive PI3K/AKT Signaling in Cancer—FRS2—nasal cavity cancer	0.0115	0.0115	CbGpPWpGaD
Isoprenaline—PIK3R2—PI3K Cascade—FRS2—nasal cavity cancer	0.011	0.011	CbGpPWpGaD
Isoprenaline—PIK3R1—Toll-like Receptor Signaling Pathway—CXCL11—nasal cavity cancer	0.011	0.011	CbGpPWpGaD
Isoprenaline—PIK3R1—FGF signaling pathway—FRS2—nasal cavity cancer	0.0107	0.0107	CbGpPWpGaD
Isoprenaline—PIK3R2—Regulation of toll-like receptor signaling pathway—CXCL11—nasal cavity cancer	0.0106	0.0106	CbGpPWpGaD
Isoprenaline—PIK3R3—PI-3K cascade—FRS2—nasal cavity cancer	0.0103	0.0103	CbGpPWpGaD
Isoprenaline—PIK3R1—SHP2 signaling—FRS2—nasal cavity cancer	0.0101	0.0101	CbGpPWpGaD
Isoprenaline—PIK3R3—PI3K/AKT activation—FRS2—nasal cavity cancer	0.0101	0.0101	CbGpPWpGaD
Isoprenaline—PIK3R3—GAB1 signalosome—FRS2—nasal cavity cancer	0.01	0.01	CbGpPWpGaD
Isoprenaline—PIK3R3—Role of LAT2/NTAL/LAB on calcium mobilization—FRS2—nasal cavity cancer	0.00977	0.00977	CbGpPWpGaD
Isoprenaline—PIK3R1—Neurotrophic factor-mediated Trk receptor signaling—FRS2—nasal cavity cancer	0.00975	0.00975	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling events regulated by Ret tyrosine kinase—FRS2—nasal cavity cancer	0.00948	0.00948	CbGpPWpGaD
Isoprenaline—MAPK1—Negative regulation of FGFR signaling—FRS2—nasal cavity cancer	0.00929	0.00929	CbGpPWpGaD
Isoprenaline—PIK3R2—IRS-mediated signalling—FRS2—nasal cavity cancer	0.00922	0.00922	CbGpPWpGaD
Isoprenaline—PIK3R2—Constitutive PI3K/AKT Signaling in Cancer—FRS2—nasal cavity cancer	0.00914	0.00914	CbGpPWpGaD
Isoprenaline—PIK3R2—IRS-related events—FRS2—nasal cavity cancer	0.00897	0.00897	CbGpPWpGaD
Isoprenaline—PIK3R1—PI3K Cascade—FRS2—nasal cavity cancer	0.00894	0.00894	CbGpPWpGaD
Isoprenaline—PIK3R2—IRS-related events triggered by IGF1R—FRS2—nasal cavity cancer	0.00889	0.00889	CbGpPWpGaD
Isoprenaline—PIK3R2—Insulin receptor signalling cascade—FRS2—nasal cavity cancer	0.00866	0.00866	CbGpPWpGaD
Isoprenaline—PIK3R2—IGF1R signaling cascade—FRS2—nasal cavity cancer	0.00866	0.00866	CbGpPWpGaD
Isoprenaline—MAPK1—FRS2-mediated cascade—FRS2—nasal cavity cancer	0.0086	0.0086	CbGpPWpGaD
Isoprenaline—MAPK1—Signalling to ERKs—FRS2—nasal cavity cancer	0.0086	0.0086	CbGpPWpGaD
Isoprenaline—PIK3R1—Regulation of toll-like receptor signaling pathway—CXCL11—nasal cavity cancer	0.00856	0.00856	CbGpPWpGaD
Isoprenaline—PIK3R2—PI-3K cascade—FRS2—nasal cavity cancer	0.00823	0.00823	CbGpPWpGaD
Isoprenaline—PIK3R2—PI3K/AKT activation—FRS2—nasal cavity cancer	0.00804	0.00804	CbGpPWpGaD
Isoprenaline—PIK3R2—GAB1 signalosome—FRS2—nasal cavity cancer	0.00797	0.00797	CbGpPWpGaD
Isoprenaline—PIK3R2—Role of LAT2/NTAL/LAB on calcium mobilization—FRS2—nasal cavity cancer	0.00779	0.00779	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling by SCF-KIT—FRS2—nasal cavity cancer	0.00772	0.00772	CbGpPWpGaD
Isoprenaline—PIK3R1—IRS-mediated signalling—FRS2—nasal cavity cancer	0.00747	0.00747	CbGpPWpGaD
Isoprenaline—MAPK1—Toll-like Receptor Signaling Pathway—CXCL11—nasal cavity cancer	0.00745	0.00745	CbGpPWpGaD
Isoprenaline—PIK3R1—Constitutive PI3K/AKT Signaling in Cancer—FRS2—nasal cavity cancer	0.0074	0.0074	CbGpPWpGaD
Isoprenaline—PIK3R3—Downstream signaling of activated FGFR—FRS2—nasal cavity cancer	0.00739	0.00739	CbGpPWpGaD
Isoprenaline—MAPK1—FGF signaling pathway—FRS2—nasal cavity cancer	0.0073	0.0073	CbGpPWpGaD
Isoprenaline—PIK3R1—IRS-related events—FRS2—nasal cavity cancer	0.00727	0.00727	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling by ERBB4—FRS2—nasal cavity cancer	0.00727	0.00727	CbGpPWpGaD
Isoprenaline—PIK3R1—IRS-related events triggered by IGF1R—FRS2—nasal cavity cancer	0.0072	0.0072	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling by Insulin receptor—FRS2—nasal cavity cancer	0.00719	0.00719	CbGpPWpGaD
Isoprenaline—PIK3R1—Insulin receptor signalling cascade—FRS2—nasal cavity cancer	0.00702	0.00702	CbGpPWpGaD
Isoprenaline—PIK3R1—IGF1R signaling cascade—FRS2—nasal cavity cancer	0.00702	0.00702	CbGpPWpGaD
Isoprenaline—PIK3R3—Downstream signal transduction—FRS2—nasal cavity cancer	0.00694	0.00694	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling by FGFR—FRS2—nasal cavity cancer	0.00691	0.00691	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling by ERBB2—FRS2—nasal cavity cancer	0.00687	0.00687	CbGpPWpGaD
Isoprenaline—PIK3R3—DAP12 signaling—FRS2—nasal cavity cancer	0.00684	0.00684	CbGpPWpGaD
Isoprenaline—PIK3R3—Downstream signaling events of B Cell Receptor (BCR)—FRS2—nasal cavity cancer	0.00674	0.00674	CbGpPWpGaD
Isoprenaline—PIK3R1—PI-3K cascade—FRS2—nasal cavity cancer	0.00667	0.00667	CbGpPWpGaD
Isoprenaline—MAPK1—Neurotrophic factor-mediated Trk receptor signaling—FRS2—nasal cavity cancer	0.00663	0.00663	CbGpPWpGaD
Isoprenaline—PIK3R1—PI3K/AKT activation—FRS2—nasal cavity cancer	0.00651	0.00651	CbGpPWpGaD
Isoprenaline—PIK3R1—GAB1 signalosome—FRS2—nasal cavity cancer	0.00646	0.00646	CbGpPWpGaD
Isoprenaline—PIK3R3—DAP12 interactions—FRS2—nasal cavity cancer	0.00644	0.00644	CbGpPWpGaD
Isoprenaline—PIK3R3—Fc epsilon receptor (FCERI) signaling—FRS2—nasal cavity cancer	0.00644	0.00644	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling by FGFR in disease—FRS2—nasal cavity cancer	0.00644	0.00644	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling by EGFR—FRS2—nasal cavity cancer	0.00638	0.00638	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling by EGFR in Cancer—FRS2—nasal cavity cancer	0.00632	0.00632	CbGpPWpGaD
Isoprenaline—PIK3R1—Role of LAT2/NTAL/LAB on calcium mobilization—FRS2—nasal cavity cancer	0.00631	0.00631	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling by PDGF—FRS2—nasal cavity cancer	0.00629	0.00629	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling by SCF-KIT—FRS2—nasal cavity cancer	0.00615	0.00615	CbGpPWpGaD
Isoprenaline—PIK3R2—BDNF signaling pathway—FRS2—nasal cavity cancer	0.00605	0.00605	CbGpPWpGaD
Isoprenaline—PIK3R3—B Cell Activation—FRS2—nasal cavity cancer	0.00596	0.00596	CbGpPWpGaD
Isoprenaline—PIK3R2—Downstream signaling of activated FGFR—FRS2—nasal cavity cancer	0.00589	0.00589	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by Insulin receptor—FRS2—nasal cavity cancer	0.00583	0.00583	CbGpPWpGaD
Isoprenaline—MAPK1—Regulation of toll-like receptor signaling pathway—CXCL11—nasal cavity cancer	0.00582	0.00582	CbGpPWpGaD
Isoprenaline—ADRBK1—Downstream signaling of activated FGFR—FRS2—nasal cavity cancer	0.0058	0.0058	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling by ERBB4—FRS2—nasal cavity cancer	0.00579	0.00579	CbGpPWpGaD
Isoprenaline—PIK3R3—NGF signalling via TRKA from the plasma membrane—FRS2—nasal cavity cancer	0.0057	0.0057	CbGpPWpGaD
Isoprenaline—PIK3R2—Downstream signal transduction—FRS2—nasal cavity cancer	0.00553	0.00553	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling by FGFR—FRS2—nasal cavity cancer	0.00551	0.00551	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling by ERBB2—FRS2—nasal cavity cancer	0.00548	0.00548	CbGpPWpGaD
Isoprenaline—PIK3R2—DAP12 signaling—FRS2—nasal cavity cancer	0.00545	0.00545	CbGpPWpGaD
Isoprenaline—ADRBK1—Downstream signal transduction—FRS2—nasal cavity cancer	0.00545	0.00545	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling by FGFR—FRS2—nasal cavity cancer	0.00542	0.00542	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling by ERBB2—FRS2—nasal cavity cancer	0.0054	0.0054	CbGpPWpGaD
Isoprenaline—PIK3R2—Downstream signaling events of B Cell Receptor (BCR)—FRS2—nasal cavity cancer	0.00537	0.00537	CbGpPWpGaD
Isoprenaline—ADRBK1—DAP12 signaling—FRS2—nasal cavity cancer	0.00537	0.00537	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling by FGFR in disease—FRS2—nasal cavity cancer	0.00513	0.00513	CbGpPWpGaD
Isoprenaline—PIK3R2—DAP12 interactions—FRS2—nasal cavity cancer	0.00513	0.00513	CbGpPWpGaD
Isoprenaline—PIK3R2—Fc epsilon receptor (FCERI) signaling—FRS2—nasal cavity cancer	0.00513	0.00513	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling by EGFR—FRS2—nasal cavity cancer	0.00508	0.00508	CbGpPWpGaD
Isoprenaline—MAPK1—IRS-mediated signalling—FRS2—nasal cavity cancer	0.00508	0.00508	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling by FGFR in disease—FRS2—nasal cavity cancer	0.00505	0.00505	CbGpPWpGaD
Isoprenaline—ADRBK1—DAP12 interactions—FRS2—nasal cavity cancer	0.00505	0.00505	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling by EGFR in Cancer—FRS2—nasal cavity cancer	0.00504	0.00504	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling by PDGF—FRS2—nasal cavity cancer	0.00502	0.00502	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling by EGFR—FRS2—nasal cavity cancer	0.00501	0.00501	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by SCF-KIT—FRS2—nasal cavity cancer	0.00499	0.00499	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling by EGFR in Cancer—FRS2—nasal cavity cancer	0.00496	0.00496	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling by PDGF—FRS2—nasal cavity cancer	0.00494	0.00494	CbGpPWpGaD
Isoprenaline—MAPK1—IRS-related events—FRS2—nasal cavity cancer	0.00494	0.00494	CbGpPWpGaD
Isoprenaline—PIK3R1—BDNF signaling pathway—FRS2—nasal cavity cancer	0.0049	0.0049	CbGpPWpGaD
Isoprenaline—MAPK1—IRS-related events triggered by IGF1R—FRS2—nasal cavity cancer	0.0049	0.0049	CbGpPWpGaD
Isoprenaline—PIK3R1—Downstream signaling of activated FGFR—FRS2—nasal cavity cancer	0.00477	0.00477	CbGpPWpGaD
Isoprenaline—MAPK1—IGF1R signaling cascade—FRS2—nasal cavity cancer	0.00477	0.00477	CbGpPWpGaD
Isoprenaline—MAPK1—Insulin receptor signalling cascade—FRS2—nasal cavity cancer	0.00477	0.00477	CbGpPWpGaD
Isoprenaline—PIK3R2—B Cell Activation—FRS2—nasal cavity cancer	0.00475	0.00475	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by ERBB4—FRS2—nasal cavity cancer	0.00469	0.00469	CbGpPWpGaD
Isoprenaline—PIK3R2—NGF signalling via TRKA from the plasma membrane—FRS2—nasal cavity cancer	0.00454	0.00454	CbGpPWpGaD
Isoprenaline—PIK3R1—Downstream signal transduction—FRS2—nasal cavity cancer	0.00448	0.00448	CbGpPWpGaD
Isoprenaline—ADRBK1—NGF signalling via TRKA from the plasma membrane—FRS2—nasal cavity cancer	0.00448	0.00448	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by FGFR—FRS2—nasal cavity cancer	0.00446	0.00446	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by ERBB2—FRS2—nasal cavity cancer	0.00444	0.00444	CbGpPWpGaD
Isoprenaline—PIK3R1—DAP12 signaling—FRS2—nasal cavity cancer	0.00442	0.00442	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling by NGF—FRS2—nasal cavity cancer	0.00438	0.00438	CbGpPWpGaD
Isoprenaline—ADRB3—Class A/1 (Rhodopsin-like receptors)—CXCL11—nasal cavity cancer	0.00436	0.00436	CbGpPWpGaD
Isoprenaline—PIK3R1—Downstream signaling events of B Cell Receptor (BCR)—FRS2—nasal cavity cancer	0.00435	0.00435	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by FGFR in disease—FRS2—nasal cavity cancer	0.00416	0.00416	CbGpPWpGaD
Isoprenaline—PIK3R1—DAP12 interactions—FRS2—nasal cavity cancer	0.00416	0.00416	CbGpPWpGaD
Isoprenaline—PIK3R1—Fc epsilon receptor (FCERI) signaling—FRS2—nasal cavity cancer	0.00416	0.00416	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by EGFR—FRS2—nasal cavity cancer	0.00412	0.00412	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by EGFR in Cancer—FRS2—nasal cavity cancer	0.00408	0.00408	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by PDGF—FRS2—nasal cavity cancer	0.00406	0.00406	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by Insulin receptor—FRS2—nasal cavity cancer	0.00396	0.00396	CbGpPWpGaD
Isoprenaline—PIK3R1—B Cell Activation—FRS2—nasal cavity cancer	0.00385	0.00385	CbGpPWpGaD
Isoprenaline—PIK3R1—NGF signalling via TRKA from the plasma membrane—FRS2—nasal cavity cancer	0.00368	0.00368	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling by NGF—FRS2—nasal cavity cancer	0.00349	0.00349	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling by NGF—FRS2—nasal cavity cancer	0.00344	0.00344	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by SCF-KIT—FRS2—nasal cavity cancer	0.00339	0.00339	CbGpPWpGaD
Isoprenaline—MAPK1—BDNF signaling pathway—FRS2—nasal cavity cancer	0.00333	0.00333	CbGpPWpGaD
Isoprenaline—ADRB3—GPCR ligand binding—CXCL11—nasal cavity cancer	0.00332	0.00332	CbGpPWpGaD
Isoprenaline—MAPK1—Downstream signaling of activated FGFR—FRS2—nasal cavity cancer	0.00324	0.00324	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by ERBB4—FRS2—nasal cavity cancer	0.00319	0.00319	CbGpPWpGaD
Isoprenaline—MAPK1—Downstream signal transduction—FRS2—nasal cavity cancer	0.00305	0.00305	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by FGFR—FRS2—nasal cavity cancer	0.00303	0.00303	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by ERBB2—FRS2—nasal cavity cancer	0.00302	0.00302	CbGpPWpGaD
Isoprenaline—MAPK1—DAP12 signaling—FRS2—nasal cavity cancer	0.003	0.003	CbGpPWpGaD
Isoprenaline—PIK3R3—GPCR downstream signaling—CXCL11—nasal cavity cancer	0.00298	0.00298	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by NGF—FRS2—nasal cavity cancer	0.00283	0.00283	CbGpPWpGaD
Isoprenaline—MAPK1—Fc epsilon receptor (FCERI) signaling—FRS2—nasal cavity cancer	0.00283	0.00283	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by FGFR in disease—FRS2—nasal cavity cancer	0.00283	0.00283	CbGpPWpGaD
Isoprenaline—MAPK1—DAP12 interactions—FRS2—nasal cavity cancer	0.00283	0.00283	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by EGFR—FRS2—nasal cavity cancer	0.0028	0.0028	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by EGFR in Cancer—FRS2—nasal cavity cancer	0.00278	0.00278	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by PDGF—FRS2—nasal cavity cancer	0.00276	0.00276	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling by GPCR—CXCL11—nasal cavity cancer	0.0027	0.0027	CbGpPWpGaD
Isoprenaline—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL11—nasal cavity cancer	0.00259	0.00259	CbGpPWpGaD
Isoprenaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL11—nasal cavity cancer	0.00253	0.00253	CbGpPWpGaD
Isoprenaline—MAPK1—NGF signalling via TRKA from the plasma membrane—FRS2—nasal cavity cancer	0.0025	0.0025	CbGpPWpGaD
Isoprenaline—PIK3R3—Innate Immune System—FRS2—nasal cavity cancer	0.0025	0.0025	CbGpPWpGaD
Isoprenaline—PIK3R3—Adaptive Immune System—FRS2—nasal cavity cancer	0.0024	0.0024	CbGpPWpGaD
Isoprenaline—PIK3R2—GPCR downstream signaling—CXCL11—nasal cavity cancer	0.00237	0.00237	CbGpPWpGaD
Isoprenaline—ADRBK1—GPCR downstream signaling—CXCL11—nasal cavity cancer	0.00234	0.00234	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling by GPCR—CXCL11—nasal cavity cancer	0.00216	0.00216	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling by GPCR—CXCL11—nasal cavity cancer	0.00212	0.00212	CbGpPWpGaD
Isoprenaline—PIK3R2—Innate Immune System—FRS2—nasal cavity cancer	0.00199	0.00199	CbGpPWpGaD
Isoprenaline—ADRB1—GPCR ligand binding—CXCL11—nasal cavity cancer	0.00197	0.00197	CbGpPWpGaD
Isoprenaline—ADRBK1—Innate Immune System—FRS2—nasal cavity cancer	0.00196	0.00196	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR ligand binding—CXCL11—nasal cavity cancer	0.00193	0.00193	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by NGF—FRS2—nasal cavity cancer	0.00192	0.00192	CbGpPWpGaD
Isoprenaline—PIK3R1—GPCR downstream signaling—CXCL11—nasal cavity cancer	0.00192	0.00192	CbGpPWpGaD
Isoprenaline—PIK3R2—Adaptive Immune System—FRS2—nasal cavity cancer	0.00191	0.00191	CbGpPWpGaD
Isoprenaline—ADRB3—GPCR downstream signaling—CXCL11—nasal cavity cancer	0.00188	0.00188	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by GPCR—CXCL11—nasal cavity cancer	0.00175	0.00175	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling by GPCR—CXCL11—nasal cavity cancer	0.0017	0.0017	CbGpPWpGaD
Isoprenaline—PIK3R1—Innate Immune System—FRS2—nasal cavity cancer	0.00161	0.00161	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—CXCL11—nasal cavity cancer	0.0016	0.0016	CbGpPWpGaD
Isoprenaline—PIK3R1—Adaptive Immune System—FRS2—nasal cavity cancer	0.00155	0.00155	CbGpPWpGaD
Isoprenaline—PIK3R3—Immune System—FRS2—nasal cavity cancer	0.00146	0.00146	CbGpPWpGaD
Isoprenaline—PIK3R3—Disease—FRS2—nasal cavity cancer	0.00134	0.00134	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—CXCL11—nasal cavity cancer	0.00127	0.00127	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—CXCL11—nasal cavity cancer	0.00125	0.00125	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—CXCL11—nasal cavity cancer	0.00119	0.00119	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—FRS2—nasal cavity cancer	0.00116	0.00116	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—FRS2—nasal cavity cancer	0.00114	0.00114	CbGpPWpGaD
Isoprenaline—ADRB1—GPCR downstream signaling—CXCL11—nasal cavity cancer	0.00111	0.00111	CbGpPWpGaD
Isoprenaline—MAPK1—Innate Immune System—FRS2—nasal cavity cancer	0.0011	0.0011	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR downstream signaling—CXCL11—nasal cavity cancer	0.00109	0.00109	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—FRS2—nasal cavity cancer	0.00107	0.00107	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—FRS2—nasal cavity cancer	0.00106	0.00106	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—CXCL11—nasal cavity cancer	0.00103	0.00103	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—CXCL11—nasal cavity cancer	0.00101	0.00101	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—CXCL11—nasal cavity cancer	0.00101	0.00101	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—CXCL11—nasal cavity cancer	0.00099	0.00099	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—FRS2—nasal cavity cancer	0.000942	0.000942	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—FRS2—nasal cavity cancer	0.000941	0.000941	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—FRS2—nasal cavity cancer	0.000868	0.000868	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—FRS2—nasal cavity cancer	0.000751	0.000751	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—FRS2—nasal cavity cancer	0.000739	0.000739	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—CXCL11—nasal cavity cancer	0.000701	0.000701	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—FRS2—nasal cavity cancer	0.000639	0.000639	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—FRS2—nasal cavity cancer	0.000608	0.000608	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CXCL11—nasal cavity cancer	0.000598	0.000598	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—FRS2—nasal cavity cancer	0.000594	0.000594	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—FRS2—nasal cavity cancer	0.00059	0.00059	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CXCL11—nasal cavity cancer	0.000585	0.000585	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—FRS2—nasal cavity cancer	0.000413	0.000413	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—FRS2—nasal cavity cancer	0.000352	0.000352	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—FRS2—nasal cavity cancer	0.000345	0.000345	CbGpPWpGaD
